tiprankstipranks
Better Therapeutics, Inc. (BTTX)
OTHER OTC:BTTX
US Market

Better Therapeutics, Inc. (BTTX) Financial Statements

164 Followers

Better Therapeutics, Inc. Financial Overview

Better Therapeutics, Inc.'s market cap is currently ―. The company's EPS TTM is $-1.157; its P/E ratio is >-0.01; Better Therapeutics, Inc. is scheduled to report earnings on May 10, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue----$ 0.00
Gross Profit-----
EBIT$ -5.34M$ -7.03M$ -8.93M$ -8.32M$ -11.00M
EBITDA-$ -6.23M$ -8.17M$ -7.60M$ -10.30M
Net Income Common Stockholders$ -5.86M$ -7.59M$ -9.36M$ -8.77M$ -11.40M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.60M$ 6.20M$ 6.07M$ 15.70M$ 22.30M
Total Assets$ 10.72M$ 11.60M$ 12.81M$ 22.94M$ 28.22M
Total Debt$ 14.31M$ 14.21M$ 14.54M$ 14.88M$ 14.79M
Net Debt$ 7.71M$ 8.02M$ 8.47M$ -820.00K$ -7.52M
Total Liabilities$ 20.66M$ 22.39M$ 22.64M$ 23.84M$ 20.97M
Stockholders Equity$ -9.94M$ -10.79M$ -9.83M$ -899.00K$ 7.25M
Cash Flow-
Free Cash Flow-$ -5.09M$ -8.74M$ -6.35M$ -7.39M
Operating Cash Flow$ -5.94M$ -5.09M$ -8.72M$ -6.34M$ -7.02M
Investing Cash Flow$ 66.00K$ -503.00K$ -521.00K$ -360.00K$ -363.00K
Financing Cash Flow$ 6.28M$ 5.72M$ -435.00K$ 132.00K$ 6.00K
Currency in USD

Better Therapeutics, Inc. Earnings and Revenue History

Better Therapeutics, Inc. Debt to Assets

Better Therapeutics, Inc. Cash Flow

Better Therapeutics, Inc. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis